Brain perfusion SPECT with Brodmann areas analysis in differentiating frontotemporal dementia subtypes.
Despite the known validity of clinical diagnostic criteria, significant overlap of clinical symptoms between Frontotemporal dementia (FTD) subtypes exists in several cases, resulting in great uncertainty of the diagnostic boundaries. We evaluated the perfusion between FTD subtypes using brain perfusion (99m)Tc-HMPAO SPECT with Brodmann areas (BA) mapping. NeuroGam software was applied on single photon emission computed tomographic (SPECT) studies for the semi-quantitative evaluation of perfusion in BA and the comparison with the software's normal database. We studied 91 consecutive FTD patients: 21 with behavioural variants (bvFTD), 39 with language variants (lvFTD) [12 with progressive non-fluent aphasia (PNFA), 27 with semantic dementia (SD)], and 31 patients with progressive supranuclear palsy (PSP)/corticobasal degeneration (CBD). Stepwise logistic regression analyses showed that the BA 28L and 32R could independently differentiate bvFTD from lvFTD, while the BA 8R and 25R could discriminate bvFTD from SD and PNFA, respectively. Additionally, BA 7R and 32R were found to discriminate bvFTD from CBD/PSP. The only BA that could differentiate SD from PNFA was 6L. BA 6R and 20L were found to independently differentiate CBD/PSP from lvFTD. Moreover, BA 20L and 22R could discriminate CBD/PSP from PNFA, while BA 6R, 20L and 45R were found to independently discriminate CBD/PSP from SD. Brain perfusion SPECT with BA mapping can be a useful additional tool in differentiating FTD variants by improving the definition of brain areas that are specifically implicated, resulting in a more accurate differential diagnosis in atypical or uncertain forms of FTD.
Varvara
V
Valotassiou
John
J
Papatriantafyllou
Nikolaos
N
Sifakis
Chara
C
Tzavara
Ioannis
I
Tsougos
Dimitrios
D
Psimadas
Eftychia
E
Kapsalaki
Ioannis
I
Fezoulidis
George
G
Hadjigeorgiou
Department of Nuclear Medicine, University Hospital of Larissa, 41110 Mezourlo Larissa, Greece. valotasiou@med.uth.gr.
Panagiotis
P
Georgoulias
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D001931:Brain Mapping; D002540:Cerebral Cortex / Q000000981:diagnostic imaging* / Q000473:pathology*; D002648:Child; D005260:Female; D057180:Frontotemporal Dementia / Q000145:classification / Q000000981:diagnostic imaging / Q000473:pathology; D007839:Functional Laterality; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D019275:Radiopharmaceuticals; D013494:Supranuclear Palsy, Progressive / Q000000981:diagnostic imaging / Q000473:pathology; D019690:Technetium Tc 99m Exametazime; D015899:Tomography, Emission-Computed, Single-Photon; D055815:Young Adult
D019275:Radiopharmaceuticals; D019690:Technetium Tc 99m Exametazime